Synonyms: AMG203 [5] | MT203
Compound class:
Antibody
Comment: Namilumab (AMG203, MT203) is an IgG1κ anti-macrophage colony-stimulating factor (GM-CSF; CSF2) monoclonal antibody [2]. It is being developed by Micromet and Nycomed for the treatment of autoimmune and chronic inflammatory diseases.
Peptide sequences and structural information for this antibody are available from its IMGT/mAb-DB entry. |
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
9382 | namilumab |
Synonyms | |
AMG203 [5] | MT203 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 367 |
Other databases | |
GtoPdb PubChem SID | 384403650 |
Search PubMed clinical trials | namilumab |
Search PubMed titles | namilumab |
Search PubMed titles/abstracts | namilumab |